Aspen Dental® announced a strategic partnership with Forward Science, a leading medical technology company, to provide enhanced periodontal care nationwide through PerioStōm®.
This innovative, non-drug treatment is now available across Aspen Dental’s network of over 1,100 independent clinics, furthering its mission to eliminate barriers to high-quality care.
According to the Centers for Disease Control and Prevention (CDC), two in five American adults have some form of periodontal disease, an inflammatory disease that affects tooth-supporting tissues and, if left untreated, can lead to tooth loss.
PerioStōm offers an advanced solution designed to protect the oral mucosa, promote gum healing, and enhance outcomes after standard periodontal treatments such as scaling and root planing.
“Aspen Dental is committed to innovation that improves patients’ lives. PerioStōm perfectly aligns with our mission to advance clinical capabilities and enhance the patient experience,” said Rute Ramalho, DDS, MS, MBA, Vice President of Health Strategy and Operations at Aspen Dental.
PerioStōm’s patented formula, using biocompatible chitosan microspheres, offers an alternative to traditional medications and is suitable for a broad range of patients, including those who cannot tolerate antibiotics after periodontal surgery.
Robert J. Whitman, CEO of Forward Science, added, “Forward Science’s mission is to transform proven technologies into cost-effective solutions that improve patients’ lives.
This collaboration with Aspen Dental underscores the role PerioStōm plays in improving patient outcomes across the United States. Together, we will innovate to create even greater impact and transform oral care.”
